Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) EBT (2021 - 2025)

Historic EBT for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to -$1.7 million.

  • Cardio Diagnostics Holdings' EBT fell 2137.74% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.6 million, marking a year-over-year increase of 2061.01%. This contributed to the annual value of -$8.4 million for FY2024, which is 7.9% down from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its EBT stood at -$1.7 million for Q3 2025, which was down 2137.74% from -$1.7 million recorded in Q2 2025.
  • Cardio Diagnostics Holdings' EBT's 5-year high stood at -$397.0 during Q2 2021, with a 5-year trough of -$4.2 million in Q1 2024.
  • Moreover, its 5-year median value for EBT was -$1.4 million (2023), whereas its average is -$1.5 million.
  • Its EBT has fluctuated over the past 5 years, first plummeted by 21199017.63% in 2022, then soared by 6798.35% in 2024.
  • Over the past 5 years, Cardio Diagnostics Holdings' EBT (Quarter) stood at -$144837.0 in 2021, then tumbled by 1541.89% to -$2.4 million in 2022, then skyrocketed by 41.59% to -$1.4 million in 2023, then fell by 9.39% to -$1.5 million in 2024, then decreased by 12.85% to -$1.7 million in 2025.
  • Its EBT was -$1.7 million in Q3 2025, compared to -$1.7 million in Q2 2025 and -$1.6 million in Q1 2025.